Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8459402 | Radiotherapy and Oncology | 2017 | 7 Pages |
Abstract
TRT added to ChT improved ES-SCLC patient OS. High dose TRT improved OS over lower doses. Our results suggest that high-dose thoracic radiation therapy may be a reasonable consideration in select patients with ES-SCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Li-Ming Xu, Lu-jun Zhao, Charles B. II, Chingyun Cheng, Minglei Kang, Xin Wang, Lin-Lin Gong, Qing-Song Pang, Jun Wang, Zhi-yong Yuan, Ping Wang,